LAMISIL AT

Adults Lamisil AT 1% Gel is applied once daily for all indications. Duration and frequency of treatment Tinea corporis, tinea cruris 1 week once a day Tinea pedis (interdigital type) 1 week once a day Relief of clinical symptoms usually occurs within a few days.

Irregular use or premature discontinuation of treatment carries the risk of recurrence. If there are no signs of improvement after two weeks, the diagnosis should be verified by a physician. Dosing in special populations Paediatric populations Not to be used in children under 16 years of age.

Experience with Lamisil AT 1% Gel in children is limited and its use cannot therefore be recommended. Elderly patients There is no evidence to suggest that elderly patients require different dosages or experience side effects different from those in younger patients.

Method of Administration For cutaneous use. Cleanse and dry the affected areas thoroughly before applying Lamisil AT 1% Gel. The gel should be rubbed in lightly to the affected skin and surrounding area. In the case of intertriginous infection (submammary, interdigital, intergluteal, inguinal) the application may be covered with a light gauze, especially at night.

Local symptoms such as pruritus, skin exfoliation, application site pain, application site irritation, pigmentation disorder, skin burning sensation, erythema, scab may occur at the site of application. These minor symptoms must be distinguished from hypersensitivity reactions such as widespread pruritus, rash, bullous eruptions and hives, which are reported in sporadical cases but require discontinuation.

In case of accidental contact with the eyes terbinafine hydrochloride may be irritating to the eyes. In rare cases the underlying fungal infection may be aggravated.

Immune system disorders Not known:

Hypersensitivity Eye disorders Rare: Eye irritation Skin and subcutaneous tissue disorders Common: Skin exfoliation, pruritus Uncommon: Skin lesion, scab, skin disorder, pigmentation disorder, erythema, skin burning sensation Rare: Dry skin, dermatitis contact, eczema Not known: Rash General disorders and administration site conditions Uncommon: Pain, application site pain, application site irritation Rare: Condition aggravated Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.

It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard.

36 mg alcohol (ethanol) in each daily dose which is equivalent to 100 mg/ g of 96% ethanol. Lamisil AT 1% Gel should be used with caution in patients with lesions where alcohol could be irritating, such as lesions which are markedly inflamed or on sensitive areas of the body such as the face.

Lamisil AT 1% Gel is for external use only. It may be irritating to the eyes. In case of accidental contact with the eyes, rinse eyes thoroughly with running water. g. contact dermatitis), or irritation to the eyes and mucous membranes.

8 mg benzyl alcohol in each daily dosage which is equivalent to 5 mg/g. Benzyl alcohol may cause mild local irritation.

1 List of Excipients).